Global Drug Repurposing Market 2024-2028

Drug Repurposing Market 2024-2028

The drug repurposing market is forecasted to grow by USD 8578.4 million during 2023-2028, accelerating at a CAGR of 4.3% during the forecast period. The report on the drug repurposing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing use of drug repurposing for cancer treatment, cost effectiveness of drug repurposing, and drug repurposing emerging as viable option for rare disease treatment.

Technavio's drug repurposing market is segmented as below:

• By Type
• Drug-centric
• Disease-centric
• Target-centric
• By Product Type
• Small molecules
• Biologics
• By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the investment in drug repurposing as one of the prime reasons driving the drug repurposing market growth during the next few years. Also, partnerships and collaborations among vendors and using ai to repurpose existing drugs will lead to sizable demand in the market.

The report on the drug repurposing market covers the following areas:

• Drug Repurposing Market sizing
• Drug Repurposing Market forecast
• Drug Repurposing Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading drug repurposing market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biogen Inc., Bristol Myers Squibb Co., Eli Lilly and Co., Gilead Sciences Inc., Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., and Vertex Pharmaceuticals Inc.. Also, the drug repurposing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.